Simultaneous determination of emtricitabine and tenofovir disoproxil fumarate in pharmaceutical preparations using spectrophotometric, chemometric and chromatographic methods Scientific paper

Main Article Content

Aysun Dinçel
https://orcid.org/0000-0002-1986-6862
E. Damla Gök Topak
https://orcid.org/0000-0002-2586-8207
Feyyaz Onur
https://orcid.org/0000-0001-9172-1126

Abstract

Simple, accurate and sensitive spectrophotometric, chemometric and chromatographic methods were used for the simultaneous determination of emt­ri­citabine (ETC) and tenofovir disoproxil fumarate (TDF) in tablets. In 1st derivative spectrophotometry, the first derivative spectra of the solution of ETC and TDF in water were recorded as ∆λ = 4 nm and the first derivative absor­ances were measured at the zero-crossing points at 297.3 and 281.2 nm for ETC and TDF, respectively. In ratio of the 1st derivative spectrophotometry measurements were recorded at 239.0 and 270.2 nm for ETC and TDF, respect­ively. Then analytical signals were measured at the wavelengths corresponding to either maximum or minimum for both drugs. For these spectrophotometric methods Beer’s law is obeyed in the concentration range of 2–15 µg mL-1 for both drugs. As chemometric method, the PLS technique was used. In chroma­to­graphic method, the separation was achieved on a C18 column with DAD (262 nm) and isocratic elution of methanol, acetonitrile and 0.1 % orthophos­phoric acid in the volume  ratio of 40:40:20, respectively, containing the mob­ile phase. The mean recovery and the relative standard deviation of the methods were found as 97.51–100.17 % and 0.55–1.26 % respectively. All these methods were statistically compared, and they were successfully applied to a pharmaceutical preparation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
[1]
A. Dinçel, E. D. Gök Topak, and F. Onur, “Simultaneous determination of emtricitabine and tenofovir disoproxil fumarate in pharmaceutical preparations using spectrophotometric, chemometric and chromatographic methods: Scientific paper”, J. Serb. Chem. Soc., vol. 89, no. 4, pp. 551–563, Apr. 2024.
Section
Analytical Chemistry

References

L. M. Bang, L. J. Scott, Drugs 63 (2003) 2413 (http://dx.doi.org/10.2165/00003495-200363220-00003)

C. Orkin, J. M. Llibre, S. Gallien, A. Antinori, G. Behrens, A. Carr, HIV Medicine 19 (2018) 18 (http://dx.doi.org/10.1111/hiv.12534)

C. Wassner, N. Bradley, Y. Lee, J. Int. Assoc. Providers AIDS Care 19 (2020) 1 (http://dx.doi.org/10.1177/2325958220919231)

K. A. Lyseng-Williamson, N. A. Reynolds, G. L. Plosker, Drugs 65 (2005) 413 (http://dx.doi.org/10.2165/00003495-200565030-00006)

C. Runja, P. R. Kumar, S. R. Avanapu, J. Chromatogr. Sci. 54 (2016) 759 (http://dx.doi.org/10.1093/chromsci/bmw004)

B. Lavanya, P. Hariprasad, A. Venkatapraveen, D.P. Lakshmi, M. Ramireddy, Pharm. Lett. 4 (2012) 99 (https://www.scholarsresearchlibrary.com/abstract/simultaneous-estimation-of-emtricitabine-and-tenofovir-disproxil-fumerate-byrnhplc-method-5960.html)

R. R. Jampala, V. K. Kumar, A. R. Nemala. Pharm. Methods 5 (2014) 7 (http://dx.doi.org/10.5530/phm.2014.1.2)

K. Anandakumara, G. Abiramia, S. Murugana, B. Ashokb, J. Anal. Chem. 68 (2013) 815 (http://dx.doi.org/10.1134/S1061934813090025)

M. Yadav, T. Mishra, P. Singhal, S. Goswami, P. S. Shrivastav, J. Chromatogr. Sci. 47(2009) 140 (http://dx.doi.org/10.1093/chromsci/47.2.140)

P. Tiwari, R. Yadav, K. Avinash, V. Vaidya, P.A. Sathe, D. Gangrade Anal. Chem. Ind. J. 9 (2010) 247 (https://www.tsijournals.com/articles/development-and-validation-of-uplc-method-for-emtricitabine-tenofovir-and-efavirenz-in-pharmaceutical-prepartion.pdf)

M. H. AbdelHay, A. A. Gazy, R. A. Shaalan, H. K. Ashour, J. Spectrosc. 2013 (2013) 937409 (https://doi.org/10.1155/2013/937409)

J. Saminathan, T. Vetrichelvan, Bangladesh Pharm. J. 19 (2016) 114 (https://doi.org/10.3329/bpj.v19i1.29247)

B. Lavanya, P. Hariprasad, A. Venkatapraveen, D. Prasannalakshmi, Int. J. Res. Pharm. Life Sci. 3 (2012) 104 (https://irjponline.com/admin/php/uploads/1542_pdf.pdf)

S. Venkatesan, N. Kannappan, Int. Scholarly Res. Notices 2014 (2014) 541727 (https://doi.org/10.1155/2014/541727)

H. K. Ashour, T. S. Belal, Arab. J. Chem. 10 (2017) S1741 (https://doi.org/10.4103/0250-474X.51951)

M. Joshi, A.P. Nikalje, M. Shahed, M. Dehghan, Ind. J. Pharm. Sci. 71 (2009) 95 (https://doi.org/10.4103/0250-474X.51951)

M.K. Matta, N.R. Pilli, S. Rao J.V.L.NA, Acta Chromatogr. 1 (2015) 27 (https://doi.org/10.1556/achrom.27.2015.1.3)

M. Takahashi, Y. Kudaka, N. Okumura, A. Hirano, K. Banno, T. Kaneda, Biol. Pharm. Bull. 30 (2007)1784 https://www.jstage.jst.go.jp/article/bpb/30/9/30_9_1784/_pdf

C. Bennetto-Hood, M.C. Long, E.P. Acosta, Rapid Commun. Mass Spectrom. 21 (2007) 2087 (https://doi.org/10.1002/rcm.3056)

S. Thomas, P. Shanmugasundramb, Ind. Drugs 55 (2018) 44 (https://doi.org/10.53879/id.55.01.10819)

V. D. Singh, V. K. Singh, S. J. Daharwal, J. AOAC Int. (2023) qsad067 (https://doi.org/10.1093/jaoacint/qsad067)

B. Morelli, J. Pharm. Biomed. Anal. 13 (1995) 219 (https://doi.org/10.1016/0731-7085(95)01250-O)

V.P. Choudhari, S. Ingale, S.R. Gite, D.D. Tajane, V.G. Modak, A. Ambekar, Pharm. Methods 2 (2011) 47 (https://doi.org/10.4103/2229-4708.81096)

M. G. Caglayan, I. M. Palabiyik, M. Bor, F. Onur, Chem. Papers 65 (2011) 754 (https://doi.org/10.2478/s11696-011-0078-2)

E. Dinc¸ I. M. Palabiyik, O. Üstundag, F. Yurtsever, F. Onur, J. Pharm. Biomed. Anal. 28 (2002) 591 (https://doi.org/10.1016/S0731-7085(01)00694-X)

I. M. Palabiyik, F. Onur, C. Yardimci, N. Özaltin, Quim. Nova 31 (2008) 1121 (https://www.scielo.br/j/qn/a/CkbxNDw4jqQx8TNzNppFJVy/)

S. Wold, M. Sjöström, L. Eriksson, Chemomet. Intell. Labor. Systems 58 (2001) 109 (https://doi.org/10.1016/S0169-7439(01)00155-1)

R. G. Brereton, Chemometrics, Data Analysis for the Laboratory and Chemical Plant, John Wiley & Sons, New York, 2002 (computer program)

ICH, Harmonized tripartite guideline validation of analytical procedures: text and methodology Q2(R1) (assessed August 31, 2023) (https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf)

ICH, Harmonized Tripartite Guideline, on validation of analytical procedures Q2(R2), ICH Steering Committee, 2022 (assessed August 31, 2023) (https://database.ich.org/sites/default/files/ICH_Q2-R2_Document_Step2_Guideline_2022_0324.pdf)